See the DrugPatentWatch profile for Sogroya
What is Sogroya, and what is it used for?
Sogroya is a prescription growth hormone treatment (somapacitan-beco) used to treat growth failure in certain children and adults who have growth hormone deficiency. [1]
Who can use Sogroya?
Sogroya is used for growth hormone deficiency in:
- Children with growth failure due to growth hormone deficiency. [1]
- Adults with growth hormone deficiency. [1]
How is Sogroya given?
Sogroya is given by injection. [1]
How does Sogroya work?
As a long-acting human growth hormone analog, somapacitan-beco is designed to replace growth hormone signaling in people who have growth hormone deficiency. [1]
What are the main safety concerns people ask about?
Common safety concerns with growth hormone therapies can include effects related to insulin-like growth factor pathways and general injection-related risks. Specific warnings and side effects for Sogroya are listed in its prescribing information. [1]
What does Sogroya cost, and how do insurance coverage and patient assistance work?
Prices and coverage vary by country, plan, and patient status. The most reliable source for current cost and support options is the product’s prescribing information and the manufacturer’s patient support resources. [1]
Where can I find the official prescribing information?
The prescribing information and detailed product details are available from the manufacturer and regulatory label sources. [1]
Sources
[1] https://www.novo-pi.com/sogroya-epi/en/home